The Latin America, Middle East and Africa Blood Collection Devices Market would witness market growth of 8.0% CAGR during the forecast period (2021-2027).
Capital investments in automated blood collection utilizing apheresis devices are high. Blood sampling or blood collection is an important aspect of diagnosing different diseases. It does not just help in tracking down the data on the excess or lack of various components in the body yet it is the first step in diagnosing any infection in the body. The hospitals and medical facilities have a wide range of blood collection systems. Whereas, there are three main ways through which blood can be collected from the patients, among which, Veinipunctures is the most commonly performed procedure.
Minimal fluid biopsy attacks are a nice method for identifying the genomic feature of DNA tumors, especially in pediatric oncology. Rising investment for product development will support the commercialization of blood collection tubes for liquid biopsy capable of incorporating in applications like PCR, NGS & DNA methylation assays.
Approximately 60% of the African children with the age of 5 or less are suffering from anemia. The prevalence of anemia in the sub-Saharan Africa region in preschool children is 42% in Swaziland to 91% in Burkina Faso. Also, 49.7% of married women in the region have anemia. The average rate of voluntary non remunerated blood donations was 67%. The lowest rate of blood donation was in Central Africa that is 34.4%.
Besides this, the percentage of reactive blood units to transfusion-transmitted infections was 4,2% of hepatitis B virus 1.3% for HIV, and 1.0% for hepatitis C virus. The cancer incidence rate is anticipated to reach 340 & 296 per 100,000 females & males simultaneously in Lebanon in 2018. This would arise the need for blood tests & collection in the LAMEA region which is likely to support the growth of the blood collection device market in this region.
The Brazil market dominated the LAMEA Blood Collection Devices Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $175.3 million by 2027. The Argentina market is poised to grow at a CAGR of 8.6% during (2021 - 2027). Additionally, The UAE market would exhibit a CAGR of 7.7% during (2021 - 2027).
Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, & Nursing Homes; Diagnostic & Pathology Laboratories, Blood Banks and Others. Based on Product, the market is segmented into Blood Collection Tubes, Needles & Syringes, Blood Bags, Blood Collection Systems/Monitors and Lancets. Based on Tubes Type, the market is segmented into Plasma/whole-blood Tubes and Serum Tubes. Based on Plasma/whole-blood Tubes Type, the market is segmented into EDTA Tubes, Heparin Tubes, Coagulation Tubes, Glucose Tubes and Others. Based on Tubes System Type, the market is segmented into Vacuum Tubes and Non-Vacuum Tubes. Based on Method, the market is segmented into Manual Blood Collection and Automatic Blood Collection. Based on Application, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Blood Collection Devices Market is Predict to reach $8 Billion by 2027, at a CAGR of 6.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sarstedt AG & Company, ICU Medical, Inc., Grifols, S.A., Retractable Technologies, Inc., Quest Diagnostics Incorporated, Becton, Dickinson and Company, Haemonetics Corporation, Terumo Corporation, Fresenius SE & Co. KGaA, and Cardinal Health, Inc.
By End User
By Product
By Tubes Type
By Plasma/whole-blood Tubes Type
By Tubes System Type
By Method
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 